Literature DB >> 18375440

Critical roles for macrophages in islet angiogenesis and maintenance during pancreatic degeneration.

Jeffery S Tessem1, Jan N Jensen, Hanna Pelli, Xu-Ming Dai, Xiao-Hua Zong, E Richard Stanley, Jan Jensen, James DeGregori.   

Abstract

OBJECTIVE: Chronic pancreatitis, characterized by pancreatic exocrine tissue destruction with initial maintenance of islets, eventually leads to insulin-dependent diabetes in most patients. Mice deficient for the transcription factors E2F1 and E2F2 suffer from a chronic pancreatitis-like syndrome and become diabetic. Surprisingly, onset of diabetes can be prevented through bone marrow transplantation. The goal of the described studies was to determine the hematopoietic cell type responsible for maintaining islets and the associated mechanism of this protection. RESEARCH DESIGN AND METHODS: Mouse models of acute and chronic pancreatitis, together with mice genetically deficient for macrophage production, were used to determine roles for macrophages in islet angiogenesis and maintenance.
RESULTS: We demonstrate that macrophages are essential for preventing endocrine cell loss and diabetes. Macrophages expressing matrix metalloproteinase-9 migrate to the deteriorating pancreas. E2f1/E2f2 mutant mice transplanted with wild-type, but not macrophage-deficient colony stimulating factor 1 receptor mutant (Csf1r(-/-)), bone marrow exhibit increased angiogenesis and proliferation within islets, coinciding with increased islet mass. A similar macrophage dependency for islet and islet vasculature maintenance is observed during caerulein-induced pancreatitis.
CONCLUSIONS: These findings demonstrate that macrophages promote islet angiogenesis and protect against islet loss during exocrine degeneration, could explain why most patients with chronic pancreatitis develop diabetes, and suggest an avenue for preventing pancreatitis-associated diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375440      PMCID: PMC2575065          DOI: 10.2337/db07-1577

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  50 in total

1.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

2.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

3.  Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization.

Authors:  Yutaka Hasegawa; Takehide Ogihara; Tetsuya Yamada; Yasushi Ishigaki; Junta Imai; Kenji Uno; Junhong Gao; Keizo Kaneko; Hisamitsu Ishihara; Hironobu Sasano; Hiromitsu Nakauchi; Yoshitomo Oka; Hideki Katagiri
Journal:  Endocrinology       Date:  2007-01-25       Impact factor: 4.736

4.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.

Authors:  Hiroaki Nozawa; Christopher Chiu; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

5.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Authors:  Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

6.  Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function.

Authors:  Marcela Brissova; Alena Shostak; Masakazu Shiota; Peter O Wiebe; Greg Poffenberger; Jeannelle Kantz; Zhongyi Chen; Chad Carr; W Gray Jerome; Jin Chen; H Scott Baldwin; Wendell Nicholson; David M Bader; Thomas Jetton; Maureen Gannon; Alvin C Powers
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

7.  The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.

Authors:  Ksenya Shchors; Elena Shchors; Fanya Rostker; Elizabeth R Lawlor; Lamorna Brown-Swigart; Gerard I Evan
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

Review 8.  Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context.

Authors:  David G Johnson; James Degregori
Journal:  Curr Mol Med       Date:  2006-11       Impact factor: 2.222

Review 9.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

Authors:  Antonio Sica; Tiziana Schioppa; Alberto Mantovani; Paola Allavena
Journal:  Eur J Cancer       Date:  2006-03-07       Impact factor: 9.162

10.  A transient microenvironment loaded mainly with macrophages in the early developing human pancreas.

Authors:  L Banaei-Bouchareb; M Peuchmaur; P Czernichow; M Polak
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

View more
  27 in total

1.  Nutritional programming of pancreatic β-cell plasticity.

Authors:  David J Hill
Journal:  World J Diabetes       Date:  2011-08-15

2.  Technical Advance: The rat aorta contains resident mononuclear phagocytes with proliferative capacity and proangiogenic properties.

Authors:  Penelope Zorzi; Alfred C Aplin; Kelly D Smith; Roberto F Nicosia
Journal:  J Leukoc Biol       Date:  2010-07-13       Impact factor: 4.962

3.  PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.

Authors:  Joao Incio; Josh Tam; Nuh N Rahbari; Priya Suboj; Dan T McManus; Shan M Chin; Trupti D Vardam; Ana Batista; Suboj Babykutty; Keehoon Jung; Anna Khachatryan; Tai Hato; Jennifer A Ligibel; Ian E Krop; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Masabumi Shibuya; Peter Carmeliet; Raquel Soares; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

Review 4.  Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.

Authors:  Naomi Van Gassen; Willem Staels; Eva Van Overmeire; Sofie De Groef; Mozhdeh Sojoodi; Yves Heremans; Gunter Leuckx; Mark Van de Casteele; Jo A Van Ginderachter; Harry Heimberg; Nico De Leu
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

Review 5.  Islet inflammation in type 2 diabetes and physiology.

Authors:  Kosei Eguchi; Ryozo Nagai
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

6.  Aurora Kinase A is critical for the Nkx6.1 mediated β-cell proliferation pathway.

Authors:  Amanda Hobson; Carrie Draney; Andrew Stratford; Thomas C Becker; Danhong Lu; Michelle Arlotto; Jeffery S Tessem
Journal:  Islets       Date:  2015-06-01       Impact factor: 2.694

7.  Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration.

Authors:  Fong Cheng Pan; Eric D Bankaitis; Daniel Boyer; Xiaobo Xu; Mark Van de Casteele; Mark A Magnuson; Harry Heimberg; Christopher V E Wright
Journal:  Development       Date:  2013-01-16       Impact factor: 6.868

8.  Short-term high-fat feeding induces islet macrophage infiltration and β-cell replication independently of insulin resistance in mice.

Authors:  David C Woodland; Wei Liu; Jacky Leong; Mallory L Sears; Ping Luo; Xiaojuan Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-30       Impact factor: 4.310

9.  CDK4, pRB and E2F1: connected to insulin.

Authors:  Lluis Fajas; Emilie Blanchet; Jean-Sébastien Annicotte
Journal:  Cell Div       Date:  2010-02-05       Impact factor: 5.130

Review 10.  The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.

Authors:  Décio L Eizirik; Maikel L Colli; Fernanda Ortis
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.